Share
4,460 Posts.
lightbulb Created with Sketch. 4588
clock Created with Sketch. 25/02/25
11:29
Share
Originally posted by Marv1n:
↑
Clinical trials.gov says that for the " Phase 1b, a combination dose-escalation of IMU-201 (PD1-Vaxx) with atezolizumab and with or without chemotherapy, will enroll approximately 18-36 patients and establish the optimal combotherapy biological dose (cBOD)." There are 24 patients in the study, which is about in the middle of the number estimated. They are not recruiting now because the trial will end shortly. Not sure how you get "mothballed" out of this
Expand
Read it again.
(20min delay)